Biotech · Public company · Malvern, PA, US
Ocugen, Inc.
Ticker OCGN · SEC CIK 0001372299
Track this companyFree. Adds Ocugen, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials126 recruiting or active
Pipeline programs17From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline17
- BBV152Phase 3 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- Brimonidine TartratePhase 3 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- Brimonidine TartratePhase 3 · Graft Versus Host DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- OCU410Phase 3 · Dry Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- OCU410STPhase 3 · Stargardt DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Sub-Retinal Administration of OCU400-301Phase 3 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- BrimonidinePhase 2 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- Brimonidine Mono TherapyPhase 2 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- Corticosteroid Eye DropPhase 2 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- OCU400 High DosePhase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- OCU400 Low DosePhase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- OCU400 Med DosePhase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- OCU400 Second Eye DosingPhase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- OCU410Phase 2 · Geographic AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- sodium carboxymethylcellulosePhase 2 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- OCU200Phase 1 · Center Involved Diabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- OCU400Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials12
- Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMDPHASE3 · RECRUITING · started Aug 11, 2026ClinicalTrials.gov NCT07770828 · fetched Nov 12, 2026
- A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis PigmentosaPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 18, 2024ClinicalTrials.gov NCT06388200 · fetched Nov 12, 2026
- Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)PHASE1 · RECRUITING · started Jan 13, 2024ClinicalTrials.gov NCT05802329 · fetched Nov 12, 2026
- Study to Assess the Safety and Efficacy of OCU410 for Geographic AtrophyPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Oct 27, 2023ClinicalTrials.gov NCT06018558 · fetched Nov 12, 2026
- A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt DiseasePHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Aug 25, 2023ClinicalTrials.gov NCT05956626 · fetched Nov 12, 2026
- Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy AdultsPHASE2_PHASE3 · UNKNOWN · started Feb 20, 2022ClinicalTrials.gov NCT05258669 · fetched Nov 12, 2026
- Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital AmaurosisPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 24, 2022ClinicalTrials.gov NCT05203939 · fetched Nov 12, 2026
- Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host DiseasePHASE3 · TERMINATED · started Dec 23, 2018ClinicalTrials.gov NCT03591874 · fetched Nov 12, 2026
- Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED)PHASE3 · COMPLETED · started Dec 3, 2018ClinicalTrials.gov NCT03785340 · fetched Nov 12, 2026
- Dry Eye Disease Study With BrimonidinePHASE2 · COMPLETED · started Sep 6, 2017ClinicalTrials.gov NCT03418727 · fetched Nov 12, 2026
- Expanded Access Program of Whole, Inactivated COVID-19 Vaccine COVAXIN™ (BBV152) in Adults Aged 18 Years and OlderNO_LONGER_AVAILABLEClinicalTrials.gov NCT05541289 · fetched Nov 12, 2026
- Expanded Access Program for RP in AdultsNO_LONGER_AVAILABLEClinicalTrials.gov NCT06574997 · fetched Nov 12, 2026
SEC filings12
- 8-K · FORM 8-KSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 15, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 15, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 23, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Sep 8, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 13, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 11, 2026 · fetched Nov 12, 2026